FDA Drug Recalls

Recalls / Class II

Class IID-611-2013

Product

0.9% Sodium Chloride Injection, USP, Polyolefin Flexible Container, a) 500 mL (NDC 0409-7983-30), b) 1000 mL (NDC 0409-7983-48), c) 250 mL (NDC 0409-7983-02), d) 150 mL (NDC 0409-7983-61), Rx Only, by Hospira, Inc., Lake Forest, IL 60045

Affected lot / code info
Lot #: a) 89-135-JT, 04-224-JT, 07-138-JT, Exp 4/13, 08-160-JT Exp. 8/13 ; b) 08-163-JT, 90-036-JT, 02-048-JT, Exp 2/13; c) 93-102-JT, 11-063-JT, Exp 9/12; d) 93-096-JT, Exp 11/12

Why it was recalled

Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.

Recalling firm

Firm
Hospira Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
275 N Field Dr, Lake Forest, Illinois 60045-2579

Distribution

Quantity
2,137,660 units
Distribution pattern
Nationwide Puerto Rico, U.S. Virgin Island, Libya, Saudi Arabia

Timeline

Recall initiated
2012-05-04
FDA classified
2013-06-21
Posted by FDA
2013-07-03
Terminated
2015-07-17
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-611-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls